These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15850805)

  • 1. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
    Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
    Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
    Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
    J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
    Shimazaki T; Honda M; Kaneko S; Kobayashi K
    Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R; Ramamurthy SS; Das S
    J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein.
    Kanda T; Gauss-Müller V; Cordes S; Tamura R; Okitsu K; Shuang W; Nakamoto S; Fujiwara K; Imazeki F; Yokosuka O
    J Viral Hepat; 2010 Sep; 17(9):618-23. PubMed ID: 19889140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation.
    Kanda T; Wu S; Kiyohara T; Nakamoto S; Jiang X; Miyamura T; Imazeki F; Ishii K; Wakita T; Yokosuka O
    Viral Immunol; 2012 Oct; 25(5):379-86. PubMed ID: 23035851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yellow fever 5' noncoding region as a potential element to improve hepatitis C virus production through modification of translational control.
    Malet I; Wychowski C; Huraux JM; Agut H; Cahour A
    Biochem Biophys Res Commun; 1998 Dec; 253(2):257-64. PubMed ID: 9878525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site.
    Kanda T; Zhang B; Kusov Y; Yokosuka O; Gauss-Müller V
    Biochem Biophys Res Commun; 2005 May; 330(4):1217-23. PubMed ID: 15823573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine as a regulator of internal ribosome entry site.
    Chen YJ; Zeng SJ; Hsu JT; Horng JT; Yang HM; Shih SR; Chu YT; Wu TY
    Acta Pharmacol Sin; 2008 Nov; 29(11):1327-33. PubMed ID: 18954527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism.
    Wiklund L; Spångberg K; Goobar-Larsson L; Schwartz S
    J Hum Virol; 2001; 4(2):74-84. PubMed ID: 11437317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
    Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
    Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation.
    Jubin R; Murray MG; Howe AY; Butkiewicz N; Hong Z; Lau JY
    J Infect Dis; 2000 Jan; 181(1):331-4. PubMed ID: 10608783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
    Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
    Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.
    Yang L; Kiyohara T; Kanda T; Imazeki F; Fujiwara K; Gauss-Müller V; Ishii K; Wakita T; Yokosuka O
    Virol J; 2010 Sep; 7():212. PubMed ID: 20815893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interference between two unrelated internal ribosome entry site elements impairs translation efficiency.
    Reigadas S; Pacheco A; Ramajo J; López de Quinto S; Martinez-Salas E
    FEBS Lett; 2005 Dec; 579(30):6803-8. PubMed ID: 16330032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation.
    Zhang B; Morace G; Gauss-Müller V; Kusov Y
    Nucleic Acids Res; 2007; 35(17):5975-84. PubMed ID: 17726047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
    Paek KY; Kim CS; Park SM; Kim JH; Jang SK
    J Virol; 2008 Dec; 82(24):12082-93. PubMed ID: 18842733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
    Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines.
    Koev G; Duncan RF; Lai MM
    Virology; 2002 Jun; 297(2):195-202. PubMed ID: 12083818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.